Less than 1% of FDA-cleared AI devices tested for clinical benefits

A study finds less than 1% of over 1,300 FDA-cleared AI medical devices have been tested for patient-centred clinical benefits, highlighting a significant evidence gap. The FDA currently uses the 510(k) clearance pathway which does not require proof of safety or effectiveness, and clinical validation is mostly industry-led, focusing on accuracy rather than patient outcomes.

This Wire brief sits within Fusion42's coverage of Health.